Natural Killer Cells in Antitumor Adoptive Cell Immunotherapy

Scientists describe the various approaches to augment natural killer (NK) cell cytotoxicity and longevity, evaluate challenges and opportunities, and reflect on how lessons learned from the clinic will guide the design of next-generation NK cell products that will address the unique complexities of each cancer.